1 |
李光鹏, 白春玲, 魏著英, 等. 黄牛Myostatin基因编辑研究[J]. 内蒙古大学学报(自然科学版), 2020, 51(1):12-32.
|
2 |
王鑫, 高广琦, 魏著英, 等. 杂交F1代myostatin基因编辑肉牛的肉质特性分析[J]. 中国牛业科学, 2018, 44(3):1-7.
|
3 |
CLOP A, MARCQ F, TAKEDA H, et al.. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep[J]. Nat. Genet., 2006, 38:813-818.
|
4 |
MOSHER D S, QUIGNON P, BUSTAMANTE C D, et al.. A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs[J/OL]. PLoS Genet., 2007, 3:e79[2021-06-10]. . DOI:10.1371/journal.pgen. 0030079 .
|
5 |
BI Y, HUA Z, LIU X, et al.. Isozygous and selectable marker-free MSTN knockout cloned pigs generated by the combined use of CRISPR/Cas9 and Cre/LoxP[J/OL]. Sci. Rep., 2016, 6:31729[2021-06-10]. .
|
6 |
WANG X, NIU Y, ZHOU J, et al.. CRISPR/Cas9-mediated MSTN disruption and heritable mutagenesis in goats causes increased body mass[J]. Anim. Genet., 2018, 49(1):43-51.
|
7 |
LEE J, KIM D H, LEE K, et al.. Muscle hyperplasia in Japanese quail by single amino acid deletion in MSTN propeptide[J/OL]. Int. J. Mol. Sci., 2020, 21(4): 1504[2021-06-10]. .
|
8 |
肖卫华, 陈佩杰, 刘宇. 巨噬细胞在骨骼肌急性损伤修复中的作用研究进展[J]. 中国运动医学杂志, 2014, 33(3):269-274.
|
9 |
TAYLOR W E, BHASIN S, ARTAZA J, et al.. Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells[J]. Am. J. Physiol. Endocrinol. Metab., 2001, 280(2):E221-E228.
|
10 |
YABLONKA-REUVENI Z. Development and postnatal regulation of adult myoblasts[J]. Microsc. Res. Tech., 1995, 30(5):366-380.
|
11 |
刘超武, 杨倬, 赵斌, 等. 逆转录病毒载体介导的RNA干扰稳定抑制肌肉生长抑制素GDF-8的表达[J]. 生物工程学报, 2008(2):250-255.
|
12 |
高丽. Myostatin基因编辑牛肌肉卫星细胞成分化过程中DNA甲基化修饰的作用机制研究[D]. 呼和浩特:内蒙古大学, 博士学位论文, 2019.
|
13 |
PATEL A K, TRIPATHI A K, PATEL U A, et al.. Myostatin knockdown and its effect on myogenic gene expression program in stably transfected goat myoblasts[J]. In Vitro Cell. Dev. Biol. Anim., 2014, 50(7):587-596.
|
14 |
CARLSON M E, HSU M, CONBOY I M. Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells[J]. Nature, 2008, 454(7203):528-532.
|
15 |
YANG W, ZHANG Y, LI Y, et al.. Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/AKT/GSK-3 beta pathway and is antagonized by insulin-like growth factor 1[J]. J. Biol. Chem., 2007, 282(6):3799-3808.
|
16 |
WANG K, TANG X, XIE Z, et al.. CRISPR/Cas9-mediated knockout of myostatin in Chinese indigenous Erhualian pigs[J]. Transgenic Res., 2017, 26(6):799-805.
|
17 |
YU B, LU R, YUAN Y, et al.. Efficient TALEN-mediated myostatin gene editing in goats[J]. BMC Dev. Biol., 2016, 16(1):26-33.
|
18 |
KOLLIAS H D, MCDERMOTT J C. Transforming growth factor-beta and myostatin signaling in skeletal muscle[J]. J. Appl. Physiol., 2008, 104:579-587.
|
19 |
ZHU X, TOPOUZIS S, LIANG L F, et al.. Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism[J]. Cytokine, 2004, 26(6):262-272.
|
20 |
ZHANG Y N, WANG Y J, BI Y L, et al.. CRISPR/Cas9-mediated sheep MSTN gene knockout and promote sSMSCs differentiation[J]. J. Cell. Biochem., 2019, 120:1794-1806.
|
21 |
GAO L, YANG M M, WEI Z Y, et al.. MSTN mutant promotes myogenic differentiation by increasing demethylase TET1 expression via the SMAD2/SMAD3 pathway[J]. Int. J. Biol. Sci., 2020, 16(8):1324-1334.
|
22 |
LI R, ZENG W, MA M, et al.. Precise editing of myostatin signal peptide by CRISPR/Cas9 increases the muscle mass of Liang Guang Small Spotted pigs[J]. Transgenic Res., 2020, 29(1):149-163.
|
23 |
LIPINA C, KENDALL H, MCPHERRON A C, et al.. Mechanisms involved in the enhancement of mammalian target of rapamycin signaling and hypertrophy in skeletal muscle of myostatin-deficient mice[J]. FEBS Lett., 2010, 584:2403-2408.
|
24 |
ROMMEL C, BODINE S C, CLARKE B A, et al.. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways[J]. Nat. Cell Biol., 2001, 3(11):1009-1013.
|
25 |
MORISSETTE M R, COOK S A, BURANASOMBATI C, et al.. Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt[J]. Am. J. Physiol. Cell Physiol., 2009, 297(5):1124-1132.
|
26 |
TRENDELENBURG A U, MEYER A, ROHNER D, et al.. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size[J]. Am. J. Physiol. Cell Physiol., 2009, 296(6):1258-1270.
|
27 |
AMIROUCHE A, DURIEUX A C, BANZET S, et al.. Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle[J]. Endocrinology, 2009, 150(1):286-294.
|
28 |
LIPINA C, KENDALL H, MCPHERRON A C, et al.. Mechanisms involved in the enhancement of mammalian target of rapamycin signaling and hypertrophy in skeletal muscle of myostatin-deficient mice[J]. FEBS Lett., 2010, 584(11):2403-2408.
|
29 |
SARTORI R, MILAN G, PATRON M, et al.. Smad2 and 3 transcription factors control muscle mass in adulthood[J]. Am. J. Physiol. Cell Physiol., 2009, 296(6):1248-1257.
|
30 |
LIU J, PAN M, HUANG D, et al.. Myostatin-1 inhibits cell proliferation by inhibiting the mTOR signal pathway and MRFs, and activating the ubiquitin-proteasomal system in skeletal muscle cells of Japanese flounder Paralichthys olivaceus [J/OL]. Cells, 2020, 9(11):2376[2021-06-10]. .
|
31 |
LIU D, QIAO X, GE Z, et al.. IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway[J/OL]. Skelet. Muscle, 2019, 9(1):8[2021-06-10]. .
|
32 |
HAN H Q, ZHOU X, MITCH W E, et al.. Myostatin/activin pathway antagonism: molecular basis and therapeutic potential[J]. Int. J. Biochem. Cell Biol., 2013, 45(10):2333-2347.
|
33 |
GUTTRIDGE D C. A TGF-beta pathway associated with cancer cachexia[J]. Nat. Med., 2015, 21:1248-1249.
|
34 |
WANG Y, YAN X, LIU H, et al.. Effect of thermal manipulation during embryogenesis on the promoter methylation and expression of myogenesis-related genes in duck skeletal muscle[J]. J. Therm. Biol., 2019, 80:75-81.
|
35 |
JONES T I, KING O D, HIMEDA C L, et al.. Individual epigenetic status of the pathogenic D 4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy[J/OL]. Clin. Epigenet., 2015, 7:37[2021-06-10]. .
|
36 |
JONES T I, YAN C, SAPP P C, et al.. Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing[J/OL]. Clin. Epigenet., 2014, 6:23[2021-06-10]. .
|
37 |
LEMMERS R J, GOEMAN J J, VLIET P JVAN DER, et al.. Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2[J]. Hum. Mol. Genet., 2015, 24:659-669.
|
38 |
MATTHEW G G, STUART S L, LAURIE A B, et al.. A chromatin landmark and transcription initiation at most promoters in human cells[J]. Cell, 2007,130(1):77-88.
|
39 |
WANG S, SUN Y, REN R, et al.. H3K27me3 depletion during differentiation promotes myogenic transcription in porcine satellite cells[J/OL]. Genes, 2019,10:231[2021-06-10]. .
|
40 |
ASP P, BLUM R, VETHANTHAM V, et al.. Genome-wide remodeling of the epigenetic landscape during myogenic differentiation[J]. Proc. Natl. Acad. Sci. USA, 2011, 108(22): E149-E158.
|
41 |
CARETTI G, DI PADOVA M, MICALES B, et al.. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation[J]. Genes Dev., 2004,18(21): 2627-2638.
|
42 |
WEI C, REN H, XU L, et al.. Signals of Ezh 2, Src, and Akt involve in myostatin-Pax7 pathways regulating the myogenic fate determination during the sheep myoblast proliferation and differentiation[J/OL]. PLoS ONE, 2015, 10(3): e0120956[2021-06-10]. .
|
43 |
BYRNE K, MCWILLIAM S, VUOCOLO T, et al.. Genomic architecture of histone 3 lysine 27 trimethylation during late ovine skeletal muscle development[J]. Anim. Genet., 2014, 45(3):427-438.
|
44 |
BAAR K. Epigenetic control of skeletal muscle fibre type[J]. Acta Physiol., 2010, 199:477-487.
|
45 |
GAO L, YANG M M, WANG X Q, et al.. MSTN knockdown decreases the trans-differentiation from myocytes to adipocytes by reducing Jmjd3 expression via the SMAD2/SMAD3 complex[J]. Biosci. Biotechnol. Biochem., 2019, 83(11):2090-2096.
|
46 |
JARVINEN T A, JARVINEN T L, KAARIAINEN M, et al.. Muscle injuries: biology and treatment[J]. Am. J. Sports Med., 2005, 33(5):745-764.
|
47 |
CHARGE S B, RUDNICKI M A. Cellular and molecular regulation of muscle regeneration[J]. Physiol. Rev., 2004, 84(1):209-238.
|
48 |
MURRAY P J, ALLEN J E, BISWAS S K, et al.. Macrophage activation and polarization: nomenclature and experimental guidelines[J]. Immunity, 2014, 41(1):14-20.
|
49 |
郑莉芳, 陈佩杰, 周永战, 等. 老年骨骼肌再生能力受损的机制研究进展[J]. 生理科学进展, 2017, 48(5):393-397.
|
50 |
MARTINEZ F O, GORDON S. The M 1 and M2 paradigm of macrophage activation: time for reassessment[J/OL]. F1000Prime Rep., 2014, 6:13[2021-06-10]. . DOI: 10.12703/P6-13 .
|
51 |
MILLS C D. Anatomy of a discovery: M1 and M2 macrophages[J/OL]. Front. Immunol., 2015, 6:212[2021-06-10]. .
|
52 |
VILLALTA S A, NGUYEN H X, DENG B, et al.. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy[J]. Hum. Mol. Genet., 2009, 18(3):482-496.
|
53 |
TIDBALL J G, VILLALTA S A. Regulatory interactions between muscle and the immune system during muscle regeneration[J]. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2010, 298(5):1173-1187.
|
54 |
TIDBALL J G. Mechanisms of muscle injury, repair, and regeneration[J]. Compr. Physiol., 2011, 1(4):2029-2062.
|
55 |
BOIS P R, GROSVELD G C. FKHR(FOXO1a) is required for myotube fusion of primary mouse myoblasts[J]. EMBO J., 2003, 22(5):1147-1157.
|
56 |
MATTHEW G M, DAVID L H, MARK P, et al.. Inhibition of myostatin signaling through Notch activation following acute resistance exercise[J/OL]. PLoS ONE, 2013, 8(7): e68743[2021-06-10]. .
|
57 |
ENDO T. Molecular mechanisms of skeletal muscle development, regeneration, and osteogenic conversion[J]. Bone, 2015, 80:2-13.
|
58 |
WOZNIAK A C, PILIPOWICZ O, YABLONKA-REUVENI Z, et al.. C-Met expression and mechanical activation of satellite cells on cultured muscle fibers [J]. J. Histochem. Cytochem., 2003, 51(11):1437-1445.
|
59 |
LIPINA C, KENDALL H, MCPHERRON A C, et al.. Mechanisms involved in the enhancement of mammalian target of rapamycin signaling and hypertrophy in skeletal muscle of myostatin-deficient mice[J]. FEBS Lett., 2010, 584:2403-2408.
|
60 |
TANG L, AN S, ZHANG Z, et al.. MSTN is a key mediator for low-intensity pulsed ultrasound preventing bone loss in hindlimb-suspended rats[J/OL]. Bone, 2021, 143:115610[2021-06-10]. .
|